当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 现金流量表

康泰医学

(300869)

  

流通市值:29.93亿  总市值:45.60亿
流通股本:2.64亿   总股本:4.02亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金255,439,255.57126,491,559.89492,702,503.02361,874,584.12
  收到的税费返还63,795.9263,795.926,879,099.438,639,820.67
  收到其他与经营活动有关的现金10,956,513.095,410,228.9122,708,744.1517,941,846.69
  经营活动现金流入小计266,459,564.58131,965,584.72522,290,346.6388,456,251.48
  购买商品、接受劳务支付的现金89,555,379.7934,458,004.08187,492,578.21133,084,073.55
  支付给职工以及为职工支付的现金89,838,87644,233,625178,053,039.89131,325,164.25
  支付的各项税费8,441,689.964,777,776.2714,623,229.8620,316,927.25
  支付其他与经营活动有关的现金45,183,753.2121,868,904.7119,834,055.3284,129,192.86
  经营活动现金流出小计233,019,698.96105,338,310.05500,002,903.28368,855,357.91
  经营活动产生的现金流量净额33,439,865.6226,627,274.6722,287,443.3219,600,893.57
二、投资活动产生的现金流量:
  收回投资收到的现金1,210,000,000664,822,958.734,027,202,478.33490,000,000
  取得投资收益收到的现金50,369,356.1621,661,735.8552,270,604.6522,026,863.85
  处置固定资产、无形资产和其他长期资产收回的现金净额--143,029.232,000
  收到的其他与投资活动有关的现金882,267,077.41150,000,000-2,472,924,300.24
  投资活动现金流入小计2,142,636,433.57836,484,694.584,079,616,112.182,984,983,164.09
  购建固定资产、无形资产和其他长期资产支付的现金9,104,110.263,915,426.5949,477,794.1532,769,079.8
  投资支付的现金1,390,000,000794,887,959.053,802,349,675.03950,000,000
  支付其他与投资活动有关的现金532,449,128.32-01,968,008,573.24
  投资活动现金流出小计1,931,553,238.58798,803,385.643,851,827,469.182,950,777,653.04
  投资活动产生的现金流量净额211,083,194.9937,681,308.94227,788,64334,205,511.05
三、筹资活动产生的现金流量:
  取得借款收到的现金25,000,00025,000,000275,000,000227,000,000
  收到其他与筹资活动有关的现金--22,058,194.4422,010,000
  筹资活动现金流入小计25,000,00025,000,000297,058,194.44249,010,000
  偿还债务支付的现金145,000,00015,424,150.37120,000,00090,000,000
  分配股利、利润或偿付利息支付的现金2,052,285.91,274,594.39112,108,790.19110,878,192.68
  支付其他与筹资活动有关的现金13,425,712.38706,467.961,428,776.251,394,382.22
  筹资活动现金流出小计160,477,998.2817,405,212.72233,537,566.44202,272,574.9
  筹资活动产生的现金流量净额-135,477,998.287,594,787.2863,520,62846,737,425.1
四、汇率变动对现金及现金等价物的影响-27,328,087.9-13,346,067.85-15,181,674.71-6,992,635.8
五、现金及现金等价物净增加额81,716,974.4358,557,303.04298,415,039.6193,551,193.92
  加:期初现金及现金等价物余额982,722,811.09982,722,811.09684,307,771.48684,307,771.48
  期末现金及现金等价物余额1,064,439,785.521,041,280,114.13982,722,811.09777,858,965.4
补充资料:
  净利润-49,267,983.28--24,423,861.05-
  资产减值准备33,668,249.14-28,148,237.76-
  固定资产和投资性房地产折旧12,327,389.18-23,346,261.61-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,054,787.98-21,425,276.04-
    投资性房地产折旧1,272,601.2-1,920,985.57-
  无形资产摊销1,373,723.31-2,372,292.95-
  长期待摊费用摊销10,959.48-23,994.45-
  递延收益摊销-389,102.42--721,533-
  处置固定资产、无形资产和其他长期资产的损失84,751.5-166,264.31-
  固定资产报废损失0---
  公允价值变动损失-2,327,222.03--1,773,267.48-
  财务费用34,074,190.28-20,228,674.56-
  投资损失-8,367,926.28--16,729,120.38-
  递延所得税-1,408,158.88--3,450,196.45-
  其中:递延所得税资产减少-1,352,638.71--3,361,859.4-
    递延所得税负债增加-55,520.17--88,337.05-
  存货的减少-15,910,993.17-14,593,917.37-
  经营性应收项目的减少4,058,970.58--10,461,192.21-
  经营性应付项目的增加24,921,918.01--10,716,107.01-
  现金的期末余额1,064,439,785.52-982,722,811.09-
  减:现金的期初余额982,722,811.09-684,307,771.48-
  现金及现金等价物的净增加额81,716,974.43-298,415,039.61-
公告日期2026-08-282026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑